DSOs Are Copying Amazon's Playbook. Most Will Fail.

DSOs Are Copying Amazon's Playbook. Most Will Fail.

You've probably heard it from a DSO pitch deck or a practice consultant: "Amazon built scale through aggressive market penetration, low margins, and reinvestment. That's what we're doing in dental."

This is the wrong analogy, and it's driving bad decisions that are bankrupting DSOs.

The Amazon comparison sounds smart. It makes scale sound inevitable. But it ignores something critical: Amazon had something unique to use. DSOs don't.

OPERATOR MATH

Let's model the actual economics of a DSO acquisition using real numbers.

Scenario: Mid-sized DSO acquires your $1.8M revenue practice generating $540,000 EBITDA (30% margin).

Acquisition price: 5.0x EBITDA = $2,700,000.

Financing structure: 75% debt ($2,025,000), 25% equity ($675,000).

Debt terms: 7-year term, 6.5% interest rate, interest-only for first 3 years.

Year 1 carrying costs:

Debt service (interest only): $2,025,000 × 6.5% = $131,625 annually.

Corporate overhead allocation (12% of revenue): $1,800,000 × 12% = $216,000 annually.

Total annual carrying costs: $131,625 + $216,000 = $347,625.

Original practice EBITDA: $540,000.

Cash flow after carrying costs: $540,000 - $347,625 = $192,375.

That's a 64.4% reduction in operating cash flow before taxes, management incentives, or equity distributions.

But wait - it gets worse.

Post-acquisition staff attrition (industry average): 18-22% in Year 1.

Your hygienist and one assistant leave. Replacement cost: $25,000 in recruiting, onboarding, and lost productivity during transition.

Patient attrition (industry average): 3-5% of revenue in Year 1 due to doctor/staff changes and patient dissatisfaction with "corporate" feel.

Lost revenue: $1,800,000 × 4% = $72,000.

Lost EBITDA (at 30% margin): $72,000 × 30% = $21,600.

Revised Year 1 cash flow:

Original EBITDA: $540,000

Lost EBITDA from attrition: -$21,600

Adjusted EBITDA: $518,400

Carrying costs: -$347,625

Staff replacement cost: -$25,000

Net cash flow: $145,775.

That's a 73% reduction in cash flow compared to pre-acquisition. The DSO is extracting $394,225 annually in debt service, overhead, and integration costs.

Year 2-3: Debt service escalates.

Assume principal payments begin in Year 4. Interest-only payments continue at $131,625/year.

Revenue growth (DSO target): 8% annually.

Actual revenue growth (industry reality): 2-3% annually due to market saturation and integration friction.

Achieved Year 2 revenue: $1,800,000 × 1.025 = $1,845,000.

EBITDA (assuming margin compression to 28% due to inefficiencies): $1,845,000 × 28% = $516,600.

Carrying costs (12% overhead on new revenue): $1,845,000 × 12% = $221,400.

Debt service: $131,625.

Net cash flow Year 2: $516,600 - $221,400 - $131,625 = $163,575.

DSO's problem:

They need to exit at 6.5x EBITDA to generate acceptable returns for PE sponsors (20%+ IRR over 5 years).

To hit that target, EBITDA needs to grow from $540,000 to $750,000+ (39% growth) over 5 years.

Actual trajectory: EBITDA is declining due to margin compression and revenue stagnation.

Exit multiple achievable: 5.0-5.5x (market reality for underperforming DSO portfolios).

Exit valuation at Year 5: $516,600 EBITDA × 5.0x = $2,583,000.

Original acquisition cost: $2,700,000.

DSO has lost $117,000 in enterprise value, plus 5 years of debt service ($658,125 in interest payments).

Total capital loss: $117,000 + $658,125 = $775,125.

This is why DSOs are restructuring. The math never worked. Amazon's playbook requires growth and margin expansion. DSOs are achieving neither.

THE TAKEAWAY

Action items:

1. If you're considering a DSO acquisition offer, model the real economics. Don't trust their projections. Use industry averages for attrition (18-22% staff, 3-5% patients), margin compression (2-4%), and revenue growth (2-3% annually, not 8-10%).

2. Understand their exit strategy. Ask: "What EBITDA multiple do you need to achieve your target IRR?" If they say 7-9x and the market is trading at 5-6x, their math doesn't work. You're the one who will suffer when they cut costs to hit targets.

3. Negotiate earn-outs carefully. If 40-60% of your acquisition price is contingent on hitting revenue/EBITDA targets, and you know patient attrition and margin compression are likely, you're taking on massive downside risk. Demand more cash at close.

4. Stay independent if you're profitable. A $540,000 EBITDA practice that you own outright generates $540,000 in cash flow (minus taxes). Post-DSO acquisition, that same practice generates $145,775 in Year 1 cash flow. You're giving up $394,225 annually for the privilege of working for someone else.

5. If you're already in a DSO, document your practice metrics independently. Track revenue, patient counts, staff retention, and EBITDA separately from corporate reporting. If the DSO fails or sells, you want to be able to prove your practice's value independently.

The Amazon playbook works when you have network effects, pricing power, and secular tailwinds. Dentistry has none of these. DSOs are burning capital trying to force a model that doesn't fit. Don't be the practice owner who learns this the hard way.